Addressing Global Cancer Disparities
As an international leader in cancer medicine, MSK is committed to programs that extend beyond a national scope. In 2011, MSK launched the Global Cancer Disparities Initiatives (GCDI) program to help improve outcomes for people with cancer in low- and middle-income countries, with a focus on sub-Saharan Africa.
Fueling global partnerships and uniting cancer experts
Philanthropy powered the partnership that led to the establishment of MSK’s GCDI program. Today, this program is bridging the gap between MSK’s cancer experts and communities in Nigeria, Kenya, and Tanzania.
Ending cancer for life — worldwide
It’s estimated that by 2030, approximately 75% of cancer deaths worldwide will occur in low- and middle-income countries. With your support, the GCDI program can expand its collaborative research initiatives to address the global cancer burden, increase access to cancer care, and change lives in more underserved communities.
Discover how MSK’s GCDI program is improving colorectal cancer care in Nigeria
Watch the video
The impact of the GCDI program
Learn how our initiatives are advancing progress in cancer research and care around the globe. With your support, we can make an even bigger difference.
Education and training
More skilled healthcare workers are needed in sub-Saharan Africa to care for the growing number of people with cancer there. GCDI efforts are creating a sustainable network of future leaders in cancer research and care in that region.
Learn moreResearch
MSK co-founded the African Research Group for Oncology (ARGO) in 2013 to answer some of the biggest questions about cancer. ARGO is now a National Cancer Institute–recognized research consortium that includes 26 Nigerian institutions.
About ARGOClinical care
The GCDI program launched Project ECHO (Extension for Community Healthcare Outcomes) in June 2020 to amplify the capacity of healthcare providers in underserved communities to deliver best-practice cancer care.
See the workBiden Cancer Moonshot
MSK was named a key partner in a new global initiative and will lead collaborative efforts to improve cancer detection and bring the latest treatment innovations, such as immunotherapy, to people across Africa.
Read the releaseHelp MSK advance cancer care, research, and education
The MSK community is raising essential funds to accelerate advances in the most promising areas of cancer research and care, like scientific discovery.
